Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3847 Target Snapshot

5'-AMP-activated protein kinase subunit beta-1 · SINGLE PROTEIN · Homo sapiens

57Compounds
26Assays
0Approved Drugs
30.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9Y478. Use UniProt Q9Y478 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Y478 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5'-AMP-activated protein kinase subunit beta-1 as ChEMBL target CHEMBL3847, mapped to UniProt Q9Y478. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5'-AMP-activated protein kinase subunit beta-1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3847
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9Y478
5'-AMP-activated protein kinase subunit beta-1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5'-AMP-activated protein kinase subunit beta-1 is the right protein anchor across sources, using UniProt Q9Y478 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5'-AMP-activated protein kinase subunit beta-1
UniProt AccessionQ9Y478
Component TypeProtein
Sequence Length270 aa

5'-AMP-activated protein kinase subunit beta-1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5'-AMP-activated protein kinase subunit beta-1, mapped to UniProt Q9Y478. Sequence length is 270 aa.

Mapped IDQ9Y478
Review name5'-AMP-activated protein kinase subunit beta-1
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5022.0
KI3.0
EC501.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2385579 7.4 IC50 39.9 Preclinical
CHEMBL2385600 7.36 IC50 44.0 Preclinical
CHEMBL2385586 7.09 IC50 82.0 Preclinical
CHEMBL478629 6.63 IC50 234.6 Preclinical
CHEMBL2205426 6.48 Ki 333.0 Preclinical
CHEMBL3891221 6.4 IC50 400.0 Preclinical
CHEMBL3986871 6.38 IC50 420.0 Preclinical
CHEMBL3668018 6.28 IC50 527.0 Preclinical
CHEMBL2385596 6.02 IC50 960.0 Preclinical
CHEMBL513147 5.95 IC50 1122.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
11
5.5
5
6.0
2
6.5
3
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

26
Total Assays
24
Tested Compounds
1
Assay Types
Binding — 26 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 22 18 6.1
cell-based format 3 4 5.6
subcellular format 1 2 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine